Built to Change the Immune Context of Cancer

We are developing precision immunotherapies for immune-cold, therapy-resistant cancers.

OUR MISSION

Overcome cancer immunotherapy resistance

Build new generation of cancer immunotherapies for difficult-to-treat cancers.

UNMET NEED

Many cancers stay immune-cold

Current therapies leave large patient populations with limited options. Overcoming immunotherapy resistance remains a major challenge in oncology.

OUR APPROACH

Reprogram the tumor ecosystem

Tumor-directed immunomodulators to activate innate and adaptive immunity.

OUR PLATFORM

TABI™

Engineered biologics that localize immune activation within the TME.

About Modunai

ABOUT